Michael Bayewitch, PhD Dr. Bayewitch has more than 22 years of experience in the pharmaceutical industry, includin…
Dr. Bayewitch has more than 22 years of experience in the pharmaceutical industry, including in due diligence and in/out-licensing transactions, focusing on oncology, autoimmune diseases, and respiratory diseases. New York, May 15, 2023 (GLOBE NEWSWIRE) — Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has appointed Michael Bayewitch, PhD, as Vice President (VP) of Business Development and Strategy.
